Overall, specific detection of the soluble EphA2 fragment cleaved by MT1-MMP in cancer cells is likely to become a key technology of pancreatic carcinoma diagnosis using blood specimens. Here, EPHA2 is linked to exocrine pancreatic carcinoma.